Hellenic Minimally Invasive and Robotic Surgery (MIRS) Study Group, National and Kapodistrian University of Athens, Medical School, Agiou Thoma 15b, Goudi, Athens 11527, Greece.
First Department of Urology, National and Kapodistrian University of Athens, Medical School, Agiou Thoma 17, Goudi, Athens 11527, Greece.
Asian J Androl. 2023;25(4):454-461. doi: 10.4103/aja202295.
Robot-assisted surgery is the gold standard of treatment in many fields of urology. In this systematic review, we aim to report its usage in andrology and to evaluate any advantages. A systematic search of the PubMed and Cochrane Library databases was conducted to identify articles referring to robotic-assisted microsurgery in andrology. The search strategy was in line with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines and the Cochrane Handbook. The articles were then reviewed by two authors. A qualitative analysis of the articles that met the inclusion criteria was performed. Thirty-one articles that met the inclusion criteria were reviewed. The first results for robot-assisted vasovasostomy (RAVV) are encouraging as excellent patency rates, short operative times, and learning curves were achieved. Interestingly, patency rates were greater in some case series for RAVV than for microsurgical vasovasostomy, with a statistically significant difference. In addition, robot has been shown to be of great use in bypassing fibrotic changes in cases of iatrogenic vasal injuries, difficulties encountered with traditional microsurgery. In addition, the feasibility of robot-assisted microsurgery has been proven for varicocelectomy and microsurgical denervation of the spermatic cord, with acceptable improvement in sperm parameters and pain, respectively. The current evidence suggests that there are potential advantages of the use of robots in andrology. However, for robotic surgery to become incorporated into the daily use of the andrologists, large, multicenter randomized trials are needed. As robotics systems are becoming standard in urology practice, it is reasonable for one to believe that they will also find their place in andrology.
机器人辅助手术是许多泌尿外科领域的治疗金标准。在本次系统评价中,我们旨在报告其在男科中的应用,并评估其任何优势。我们对 PubMed 和 Cochrane Library 数据库进行了系统检索,以确定涉及男科机器人辅助显微手术的文章。检索策略符合系统评价和荟萃分析的首选报告项目 (PRISMA) 指南和 Cochrane 手册。然后由两名作者对文章进行了审查。对符合纳入标准的文章进行了定性分析。共审查了 31 篇符合纳入标准的文章。机器人辅助血管吻合术 (RAVV) 的初步结果令人鼓舞,因为达到了极好的通畅率、较短的手术时间和学习曲线。有趣的是,在一些 RAVV 的病例系列中,通畅率高于显微血管吻合术,且具有统计学意义。此外,机器人在绕过医源性血管损伤中的纤维性变化方面显示出巨大的作用,在传统显微手术中遇到困难。此外,机器人辅助显微手术已被证明可用于精索静脉曲张和精索神经切断术,分别可使精子参数和疼痛得到可接受的改善。目前的证据表明,机器人在男科中的应用具有潜在的优势。然而,为了使机器人手术成为男科医生日常使用的一部分,还需要进行大型、多中心的随机试验。随着机器人系统在泌尿外科实践中变得标准化,人们有理由相信它们也将在男科中找到自己的位置。